BioCentury on BioBusiness,
Tools & Techniques
Monday, February 26, 2007
Vipergen and Ensemble both use DNA oligos to perform "directed" chemistry. The difference between the two technologies is the DNA architecture.
Vipergen’s YoctoReactor uses 3-5 oligonucleotides, each attached to reactants. A chemical reaction is facilitated when the oligos hybridize and form a 3-D test tube-like space. The reactants are combined stepwise; each step includes two reactants but always requires at least three oligos. To do this, Vipergen adds dummy oligos, which are not bound to reactants, to form a complete YoctoReactor for each step. Once each reaction is complete, the oligos carrying reactants, but not the dummy oligos, are ligated. When DNA polymerase and a primer are added to make a strand complementary to the YoctoReactor oligonucleotides, the YoctoReactor dismantles to form double-stranded DNA, which is thermodynamically more stable. The newly synthesized molecule remains attached.
words displayed of
To read this article, you must be an Archives subscriber. Please choose one of the options below.
All contents Copyright © 1993-2016 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Whether you want an individual subscription or need a global group license, we have the products,
the experience and the customer support that biopharma executives, researchers, investors, service providers,
and industry stakeholders have trusted for nearly two decades.
Let our Subscriber Services team customize the best intelligence package available in the industry to meet your needs.
Free Trial Subscription 4 Weeks of Access
BioCentury's Weekly Business Intelligence Journal
Get a 4-week free trial subscription to BioCentury.
Get 4 Weeks Free
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]